Unaudited revenues up 594% on H1 2020 and 52% on H1 2019, reflecting new business model

Unaudited revenues up 594% on H1 2020 and 52% on H1 2019, reflecting new business model
Microsaic demonstrates real-time monitoring for scaling biotherapeutic production Automated system maintains high quality while allowing rapid scaling to large volumes.